Logo
Login

Company Executives

$ Management Team

Ms. Karleen Oberton

Chief Financial Officer

Age 56
Compensation $4.394M USD
Sex Female

Mr. Stephen Macmillan

Chairman of the Board

President

Chief Executive Officer

Age 61
Compensation $15.93M USD
Sex Male

Mr. Michael Watts

Corporate Vice President - Investor Relations

Age -
Compensation -
Sex Male

Mr. Mark Horvath

Division President

Breast and Skeletal Health Solutions

Age 63
Compensation -
Sex Male

Dr. Jennifer Schneiders

President - Diagnostic Solutions

Age 58
Compensation $3.135M USD
Sex Female

Mr. Brandon Schnittker

President - GYN Surgical Solutions

Age 42
Compensation -
Sex Male

Mr. Jan Verstreken

Group President - International

Age 58
Compensation $3.462M USD
Sex Male

Mr. Essex Mitchell

Chief Operating Officer

Age 46
Compensation $5.075M USD
Sex Male

Ms. Diana De Walt

Senior Vice President - Human Resources

Age 71
Compensation -
Sex Female

Ms. Anne Liddy

General Counsel

Age 50
Compensation -
Sex Female

Board of Directors

From the proxy statement filed Jan 16, 2025
Directors
10
serving now
Independent
9 of 10
stated in the proxy
Average tenure
8.5 years
from year joined
CEO also chairs the board
Yes
Stephen P. MacMillan
Director Age On board Independent Committees Other public boards 2024 pay Source
Stephen P. MacMillan
Board chair, CEO
 61 2013
12 years
 Not independent None stated Illumina, Inc. Paid as CEO
Charles J. Dockendorff
70 2017
8 years
 Independent
• Audit and Finance · Chair
Boston Scientific Corporation, Haemonetics Corporation, Keysight Technologies, Inc. $354,952
Ludwig N. Hantson
62 2018
7 years
 Independent
Compensation
None stated $329,952
Martin Madaus
65 2024
1 year
 Independent
Compensation
Azenta, Inc., Quanterix Corp., Repligen Corp. Not stated
Nanaz Mohtashami
47 2023
2 years
 Independent
Compensation
None stated $329,952
Christiana Stamoulis
54 2011
14 years
 Independent
Audit and Finance
None stated $329,952
Stacey D. Stewart
60 2023
2 years
 Independent
Audit and Finance
PennyMac Mortgage Investment Trust $329,952
Amy M. Wendell
Lead independent director
 64 2016
9 years
 Independent
Compensation Nominating and Corporate Governance · Chair
AxoGen, Inc., Baxter International Inc., Solventum Corp. $357,452
Sally W. Crawford Leaving at the meeting
71 2007
18 years
 Independent
Compensation Nominating and Corporate Governance
None stated $357,452
Scott T. Garrett Leaving at the meeting
74 2013
12 years
 Independent
Compensation · Chair Nominating and Corporate Governance
None stated $349,952

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

1 disclosed in the proxy filed Jan 16, 2025
Peter Wells
stepson of Sally Crawford, a member of our Board
Approximately $192,000
fiscal 2024

Employment of Peter Wells as an IT Business Analyst, with total annual compensation of approximately $192,000 in fiscal 2024.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans